These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21889188)

  • 1. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
    Kaneko K; Hineno A; Yoshida K; Ohara S; Morita H; Ikeda S
    Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
    Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
    Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
    Parks NE; Vandorpe RA; Moeller JJ
    Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and pathological basis of aceruloplasminemia.
    Kono S; Miyajima H
    Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain and liver iron accumulation in aceruloplasminemia.
    Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
    Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
    [No Abstract]   [Full Text] [Related]  

  • 8. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
    Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
    Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score.
    Kerkhof M; Honkoop P
    Hepatology; 2014 Apr; 59(4):1645-7. PubMed ID: 24002824
    [No Abstract]   [Full Text] [Related]  

  • 14. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
    Kaneko K; Yoshida K; Arima K; Ohara S; Miyajima H; Kato T; Ohta M; Ikeda SI
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
    Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
    Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial siderosis associated with aceruloplasminemia. Case report.
    Matsushima A; Yoshida T; Yoshida K; Ohara S; Toyoshima Y; Kakita A; Ikeda S
    J Neurol Sci; 2014 Apr; 339(1-2):231-4. PubMed ID: 24607334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial tauopathy mimicking corticobasal degeneration an autopsy study on three siblings.
    Uchihara T; Nakayama H
    J Neurol Sci; 2006 Jul; 246(1-2):45-51. PubMed ID: 16540122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up.
    Pan PL; Tang HH; Chen Q; Song W; Shang HF
    Mov Disord; 2011 Sep; 26(11):2142-4. PubMed ID: 21594898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.